
Overview
Efferta Pharma is a Polish manufacturer and supplier of dietary supplements, established in 1996. It provides contract and private-label production of supplements, including effervescent tablets, lozenges, hard capsules and powders, as well as sweetener production and packaging. The company operates a production facility and laboratory and has implemented ISO 22000, BRC and GMP systems.
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $982,678 |
Filing timeliness
Financial statements were filed on time, on average 71 days early. All were audited by a statutory auditor.
- 202520/05/2026
- 202424/04/2025
- 202318/04/2024
- 202224/04/2023
- 202127/05/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Dietary supplements
- Effervescent tablets
- Lozenges
- Hard capsules
- Powdered supplements
- Supplement packaging
- Formulation development
Websites
The sites are available in: Polish and English.
- efferta.plStrona główna - Efferta: producent i dostawca suplementów dietyWordPress 7.1ElementorYoast SEOLLiteSpeed
- efferta.euStrona główna – Efferta: producent i dostawca suplementów dietyWordPress 7.1ElementorYoast SEOLLiteSpeed
Trademarks
The company holds 12 active trademarks registered with the Polish Patent Office. The first mark was filed in 1995.
| Mark | Protected until | |
|---|---|---|
| EFFERTA PHARMA | Dec 1, 2035 | |
| ŁYŻECZKA WITAMIN (word) | Aug 5, 2034 | |
| Vitaspoon (word) | Jan 8, 2033 | |
| Fitstyle (word) | Aug 22, 2027 | |
| IRON PULS (word) | Feb 15, 2027 |
Job offers
The company has its own careers page: efferta.pl/kariera.
Authorized Representatives
Manner of representation
Two members of the management board acting jointly or a member of the management board acting jointly with a commercial proxy are authorized to represent the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 10,458 | $141,247.97 | 50% | |
| 4,394 | $59,346.30 | 21.0078% | |
| 1,673 | $22,595.89 | 7.9987% | |
| 4,391 | $59,305.78 | 20.9935% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2004-09-17.
09 1020 1026 0000 1102 0609 4066
57 1090 1753 0000 0001 6224 6408
63 1020 1026 0000 1502 0589 5018
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 1MPLN 1,025,078 |
Public aid
10 public aid cases recorded, with a total value of $347,527.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Dec 16, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $31,716$31,716 | Prezes Banku Gospodarstwa Krajowego | |
| Jun 2, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $44,668$44,668 | Prezes Banku Gospodarstwa Krajowego | |
| May 27, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $75,337$75,337 | Prezes Banku Gospodarstwa Krajowego |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Natur Produkt Pharma sp. z o.o. | $93,854,070.54 | nppharma.pl | ||
| Phytopharm Klęka S.A. | $46,154,888.31 | phytopharm.pl | ||
| Prosuplement Group sp. z o.o. | $34,819,545.29 | prosuplement.com | ||
| Exim Pharma sp. z o.o. | $24,694,130.27 | eximpharma.eu | ||
| Global Pharma Cm S.A. | $24,132,016.98 | globalpharma.pl | ||
| Symbiofarm Krok sp. k. | $16,922,181.13 | symbiofarm.pl | ||
| Europharma Alliance sp. z o.o. | $15,439,864.68 | pharmaalliance.eu | ||
| Laboratoria Natury sp. z o.o. | $13,931,403.39 | laboratorianatury.pl | ||
| Ośrodek Badawczo-Produkcyjny Politechniki Łódzkiej Ichem sp. z o.o. | $10,474,927.81 | ichem.com.pl | ||
| All4pharmacy sp. z o.o. | $5,281,269.99 | all4pharmacy.pl |
FAQ
Last updated: 2026-10-07